Description of Data on Screening Results for Infections Infectious Through Blood Transfusion (IMLTD) at Unit Donor Darah Palang Merah Indonesia DKI Jakarta Province in 2023 Rusdi1, Annisa Alfazrin1, Kadek Vicky Cintya Dewi1, Shofa Fauziah,1 Daniar Setyo Rini,1 Ni Ken Ritchie,2 Sumiyati2 Nurhayati2
1Departement of Biology Education, Faculty of Mathematics and Natural Sciences (FMIPA), Universitas Negeri Jakarta.
2 PMI Blood Donation Unit DKI Jakarta Province.
Abstract
The Blood Donor Unit (UDD) is a unit that facilitates the community, especially in the field of blood services, under the auspices of the Indonesian Red Cross (PMI). Some of the activities at UDD PMI include providing blood and distributing blood. Before blood is given to the recipient, it must first pass testing, namely the Infection Transmitted Through Blood Transfusion (IMLTD) screening test to prevent the risk of disease transmission. The aim of this research is to determine the results of examinations for Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Syphilis at UDD PMI DKI Jakarta Province in 2023. This research uses secondary data from January to December 2023 obtained from archives of screening tests and screening results for infectious infections through blood transfusion (IMLTD) on donor blood at the PMI DKI Jakarta Blood Donor Unit (UDD) in 2023. This research was conducted in February-April 2024. Detection of Infectious Infections Through Transfusion Blood (IMLTD) was performed using the chemiluminescence immunoassay (ChLIA) technique. The results show that of the 368,615 samples submitted, 3,429 samples fell into the reactive category. The number of reactive donors in 2023 for Hepatitis B testing will be 1078 (0.29%), Hepatitis C will be 796 (0.22%), HIV will be 360 (0.10%), and Syphilis will be 1195 (0.32%). The most reactive donors in 2023 for Hepatitis B will be in July, for Hepatitis C will be in December, for HIV will be in March, and for Syphilis will be in April.
